Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04LXB
|
|||
| Former ID |
DNCL003766
|
|||
| Drug Name |
Captisol-enabled Melphalan
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90; ICD-9: 203] | Phase 2 | [1] | |
| Company |
SPECTRUM pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for Captisol-Enabled (Propylene Glycol-Free) Melphalan. Spectrum Pharmaceuticals. October 23, 2015. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.